Amy is an associate in Taylor Wessing's Corporate Technology and Life Sciences team in London and specialises in acting for companies, investors and management teams on transactions in the technology and life sciences sectors.

Amy has experience of a broad range of corporate transactions, including domestic and cross-border M&A, venture capital investments and general corporate advisory work.

 

 
Show full CV Hide full CV

Latest news & insights

Patterned pills
Life sciences & healthcare

Further extension of the transition periods for medical devices under MDR and IVDR

23 March 2023
Briefing

by Bartosz Świdrak

Click here to find out more
Pink handbag Close-Up on braided handles and metal accessories
Fashion & luxury

Fashion and luxury market update

22 March 2023
Quick read

by multiple authors

Click here to find out more
MAIN_Life sciences
Life sciences & healthcare

Higher Regional Court of Hamm on the advertising ban in Sec. 12 HWG in the context of the COVID 19 pandemic

22 March 2023
Briefing

by Dr. Daniel Tietjen and Katharina Hölle

Click here to find out more
Textured facade
Corporate/M&A & capital markets

Taylor Wessing advises Emerald Technology Ventures on investment in Colibri Energy

With this investment, Emerald Technology Ventures supports the development and growth of Colibri Energy, a provider of lithium-ion battery systems for vehicles in airport and industrial logistics.

22 March 2023

by multiple authors

Click here to find out more

Related people

Meet me at

There are no upcoming events